Xenpozyme®
Xenpozyme® (olipudase alfa-rpcp) is indicated for treatment of non–central nervous system manifestations of acid sphingomyelinase deficiency (ASMD) in adult and pediatric patients.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
WHAT IT TREATS: |
MANUFACTURER: Genzyme Corporation |
CLASS: Enzyme Replacement Therapy (ERT) |
PRESCRIBED BY: Neurologists
|
HOW ADMINISTERED: IV Infusion |
FREQUENCY: Every two weeks |
Length of infusion: three - four hrs |
FOR MORE INFORMATION: |
